These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 10327138)

  • 1. Maternal serum S100 protein in normal and Down syndrome pregnancies.
    Abraha HD; Noble PL; Nicolaides KH; Sherwood RA
    Prenat Diagn; 1999 Apr; 19(4):334-6. PubMed ID: 10327138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
    Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human placental growth hormone is increased in maternal serum in pregnancies affected by Down syndrome.
    Papadopoulou E; Sifakis S; Giahnakis E; Fragouli Y; Karkavitsas N; Koumantakis E; Kalmanti M
    Fetal Diagn Ther; 2008; 23(3):211-6. PubMed ID: 18417980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal serum levels of total activin-A in first-trimester trisomy 21 pregnancies.
    Spencer K; Liao AW; Skentou H; Ong CY; Nicolaides KH
    Prenat Diagn; 2001 Apr; 21(4):270-3. PubMed ID: 11288115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15 030 pregnancies.
    Bindra R; Heath V; Liao A; Spencer K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2002 Sep; 20(3):219-25. PubMed ID: 12230441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First trimester predictors of adverse pregnancy outcomes.
    Brameld KJ; Dickinson JE; O'Leary P; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
    Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):529-35. PubMed ID: 19133038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
    Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
    Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-trimester maternal serum human thyroid-stimulating hormone in chromosomally normal and Down syndrome pregnancies.
    Weinans MJ; Pratt JJ; de Wolf BT; Mantingh A
    Prenat Diagn; 2001 Sep; 21(9):723-5. PubMed ID: 11559906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal serum anti-Mullerian hormone level is not superior to chronological age in predicting Down syndrome pregnancies.
    Li HW; Hui PW; Tang MH; Lau ET; Yeung WS; Ho PC; Ng EH
    Prenat Diagn; 2010 Apr; 30(4):320-4. PubMed ID: 20155783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics.
    Kagan KO; Wright D; Spencer K; Molina FS; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 May; 31(5):493-502. PubMed ID: 18432600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.
    Nicolaides KH; Spencer K; Avgidou K; Faiola S; Falcon O
    Ultrasound Obstet Gynecol; 2005 Mar; 25(3):221-6. PubMed ID: 15736186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
    Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
    Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down syndrome maternal serum marker screening after 18 weeks' gestation.
    Muller F; Dreux S; Oury JF; Luton D; Uzan S; Uzan M; Levardon M; Dommergues M
    Prenat Diagn; 2002 Nov; 22(11):1001-4. PubMed ID: 12424764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma amyloid beta protein 1-42 levels in fetuses with Down syndrome.
    Bartha JL; Soothill PW
    Early Hum Dev; 2005 Apr; 81(4):351-4. PubMed ID: 15814219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity.
    Muller F; Dreux S; Dupoizat H; Uzan S; Dubin MF; Oury JF; Dingeon B; Dommergues M
    Prenat Diagn; 2003 Apr; 23(4):331-5. PubMed ID: 12673641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for trisomies 21 and 18 with maternal serum placental isoferritin p43 component.
    Moroz C; Maymon R; Jauniaux E; Traub L; Cuckle H
    Prenat Diagn; 2000 May; 20(5):395-9. PubMed ID: 10820407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal cells in maternal blood: a six-fold increase in women who have undergone amniocentesis and carry a fetus with Down syndrome: a multicenter study.
    Falcidia E; Parano E; Grillo A; Pavone P; Takabayashi H; Trifiletti RR; Scollo P; Dallapiccola B; Grammatico P; Novelli A; Paladini D; Monni G; Gulisano A; Scassellati G
    Neuropediatrics; 2004 Dec; 35(6):321-4. PubMed ID: 15627938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay.
    Talbot JA; Spencer K; Abushoufa RA
    Prenat Diagn; 2003 Jan; 23(1):1-5. PubMed ID: 12533803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human chorionic gonadotropin and plasma protein-A in alpha0-thalassemia pregnancies.
    Ong CY; Lee CP; Leung KY; Lau E; Tang MH
    Obstet Gynecol; 2006 Sep; 108(3 Pt 1):651-5. PubMed ID: 16946227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Maiz N; Pandeva I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.